Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:25 AM
Study NCT ID:
NCT04416633
Status:
COMPLETED
Last Update Posted:
2024-11-08
First Post:
2020-05-27
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-27
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-02
Results First Submit QC Date:
None
Results First Post Date:
2024-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-02
Last Update Post Date:
2024-11-08
Last Update Post Date Type:
ACTUAL